Jolly Good announces new palliative care VR training module
Jolly Good in the United States, in partnership with Harvard-affiliated Brigham and Women’s Hospital, has developed a new VR training module in palliative care communication.
They came up with the VR module to help medical professionals acquire the necessary communication skills to provide care to terminally ill patients and their...
The digital healthcare business of South Korean internet company Kakao Corporation has entered into a collaboration agreement with Dexcom to set up a global digital diabetes management service.
According to a press statement, the deal combines Kakao Healthcare's capabilities in AI and software technology with Dexcom's continuous glucose monitoring (CGM) devices, Dexcom G6 and G7, which the...
Dexcom takes G6 CGM to Singapore
Global CGM device maker Dexcom has launched its latest CGM system in Singapore.
Distributed through its partner DKSH Singapore, the prick-less Dexcom G6 CGM uses a wearable sensor and transmitter to continuously measure and send glucose levels wirelessly to a compatible smart device.
It pairs with a companion mobile app on iOS and Android devices, enabling the...
DarioHealth is partnering with Dexcom to integrate the company's continuous glucose monitors into Dario's chronic-condition management platform.
The collaboration will allow Dario's digital health tools for metabolic health to include data from Dexcom CGMs, wearable sensors that automatically monitor blood glucose levels for patients with diabetes.
Dario said integrating CGM data would provide...
Dexcom announced last week that its G7 continuous glucose monitoring system has received FDA clearance.
The latest model of its CGM, which can be used by people with all types of diabetes ages 2 and up, is expected to launch in the U.S. early next year. As the company works out insurance coverage for the G7, it plans to offer cash payment options for early adopters.
The CGM fits on the back of...
At the J.P. Morgan Healthcare Conference this week, Dexcom, maker of continuous glucose monitoring systems, made waves after CEO Kevin Sayer announced new clinical trial data from its yet to be released CGM, the G7.
The 308 person trial demonstrated that the G7's mean absolute relative difference (MARD) was 8.2% for adults and 8.1% for pediatric patients. The G7 was submitted to the FDA in the...
Garmin announced a suite of apps that will allow people with diabetes who use the Dexcom G6 continuous glucose monitor (CGM) to view glucose levels and trends on their smartwatch.
The Dexcom Connect IQ apps allow users with a compatible smartwatch or cycling computer to view their glucose levels as well as a three-hour history to get a better picture of where their levels may be headed during the...
Third-party digital health companies can now integrate Dexcom’s continuous glucose monitoring data into their platforms and devices in real-time thanks to a new FDA clearance for the company’s Partner Web APIs.
The data integration capabilities are available to companies on an invite-only basis. So far, wearable device-maker Garmin and chronic-condition-management company Livongo have entered the...
Diabetes care has changed dramatically in recent years, thanks to technological developments, but some of the metrics used in the disease’s management remain outdated. That’s why Dexcom created The Global Movement for Time in Range, an educational campaign to raise awareness and adoption of time in range as the standard of care in diabetes management.
Time in range is the percentage of time spent...
Pharma giant Eli Lilly has inked a series of deals with four diabetes management companies to integrate with its forthcoming Tempo Pen and Tempo Smart Button products.
The companies that signed strategic international agreements with Eli Lilly are Dexcom, Glooko, myDiabby Healthcare and Roche.
Through the agreements, Eli Lilly’s Tempo Pen and connected Tempo Smart Button will integrate with the...